23 Iulie 2009
Pharma: executives on the move
The first six months had seen 15 major changes in local pharmaceutical companies’ top management.
Astra-Zeneca appoints former CEO of Eli Lilly
“An increasing number of companies choose to change managers, because they find people with the same management skills and expertise as before crisis, but at a lower cost”, said George Butunoiu, managing partner of the executive search George Butunoiu Ltd, and also one of the best known head-hunters in Romania.
Lars Ramneborn takes over leadership of Zentiva Romania
Before this appointment Ramneborn was vicepresident for trade at Zentiva Group. He is also member of Zentiva NV’s board of directors.
Rumors of CEO change
After six years with A&D Pharma, Nastase took over leadership of Ozone Romania in 2006, and her main objective was to increase sales and profit as well as to consolidate the subsidiary at a regional level.
Prior to joining Ozone, Marius Chereches was the managing director of PharmaFarm, a drug distributor from Transilvania, acquired by Gedeon Richter in 2007.
Actavis' CEO steps down after 10 years
Prior to this announcement made by Scheusan, Antibiotice Iasi (BSE: ATB), one of the top 10 drug producers, has passed under the leadership of Ioan Nani, one year after being replaced by the former marketing director of the company, Coca Cascaval.
In May, Catalin Radu was appointed to head the marketing operations of one of the regional divisions of German-based Bayern Healthcare.
GSK takes new CEO
He will be replaced by Patrick Desbiens, former director commercial operations for Quebec, at GSK Canada. Dana Stanciulescu resigned from her role as country manager of Teva Pharmaceuticals to get off the ground a business in pharma advisory.
Sorin Mocanu was appointed as head of local operations of Swiss-based PharmaSwiss. Iztok Sever, former leader of Swiss-based Sandoz’s operations in Romania has been promoted at the helm of Sandoz’s subsidiaries for Romania and Bulgaria.
A&D Pharma finds COO replacement
Jean-Michel Lespinasse (photo) has over 17 years experience in the pharmaceutical industry, most of it acquired during his time at Bristol-Myers Squibb (BMS) from 1996 to 2006.
Prior to joining A&D Pharma, Lespinasse had been COO of Delta Medical Russia, a provider of full range pharmaceutical promotional services in Ukraine and Russia, according to the company.
LaborMed grabbed spotlight in H1 2008
Subsequently, American investors brought at the helm of LaborMed Stephen Stead (CEO-photo), Mircea Ilie (CFO), Anca Petrescu (HR director), Adrian Stroilescu (development director), Andreea Ombas (marketing manager), Mirel Florica (operation director) and Lucian Codreanu (commercial director)